Viewing StudyNCT01624766



Ignite Creation Date: 2024-05-06 @ 12:39 AM
Last Modification Date: 2024-10-26 @ 10:52 AM
Study NCT ID: NCT01624766
Status: COMPLETED
Last Update Posted: 2021-02-25
First Post: 2012-06-19

Brief Title: Everolimus and Anakinra or Denosumab in Treating Participants With Relapsed or Refractory Advanced Cancers
Sponsor: MD Anderson Cancer Center
Organization: MD Anderson Cancer Center

Organization Data

Organization: MD Anderson Cancer Center
Class: OTHER
Study ID: 2011-1043
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: MD Anderson Cancer Center
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
National Cancer Institute NCI NIH